Skip to content

Effects of Weight Loss on Foot Structure and Function in Obese Adults: A Pilot Study

Effect of Weight Loss on Foot Structure and Function in Obese Adults: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01782144
Acronym
WLF
Enrollment
41
Registered
2013-02-01
Start date
2011-01-31
Completion date
2011-09-30
Last updated
2020-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity, Foot pain

Brief summary

Obesity is a serious medical, social, and economic problem and is becoming even greater concern, as the prevalence of overweight and obese individuals has steadily increased over the years. Excessive body weight can have a profound influence on lower extremities, including pain, degenerative disease, and compromised quality of life. However, no study to-date has examined the effects of weight change on foot structure and function in individuals over time. The purpose of this study is to determine the effects of weight reduction on foot structure and function in obese adults. Improved understanding of the relationship between body weight and foot biomechanics is needed to promote health and healthier lifestyles.

Interventions

OTHERNutriSystem portion-controlled pre-packaged meals

Sponsors

Temple University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women between the ages of 50 to 75, inclusive * Body Mass Index is ≥ 30 kg/m2 but \< 45 kg/m2 and body weight \< 300 pounds * Able to ambulate safely without the use of a walking aid (cane, crutches, or walker) * Able to understand the information in the informed consent form and is willing and able to comply with the study-related procedures

Exclusion criteria

* Diabetes, stroke, end stage kidney disease requiring hemodialysis, or widespread malignant disease, gallbladder disease * Severe peripheral vascular disease (defined as 1 \< palpable pedal pulse and claudication pain in less than two blocks) * Pregnant or nursing, as weight and hormonal changes during pregnancy may affect foot structure and function, which could confound the results of the study. Therefore, women who are pregnant or nursing will be excluded from the study. * Not willing or able to make the required quarterly follow-up visits * Insufficient (corrected) vision to complete the questionnaires * Food allergies to the Nutrisystem, Inc. meal plan used in this protocol * Participation in another formal weight loss program within last 6 months * Uncontrolled hypertension (systolic blood pressure \> 180 or diastolic blood pressure \> 100 mmHg). Participants on medication treating hypertension for at least three months are allowable. * Known atherosclerotic cardiovascular disease * History of congestive heart failure * History of a non-skin malignancy within the previous 5 years * Any major active rheumatologic, pulmonary, hepatic, renal, dermatologic disease or inflammatory condition

Design outcomes

Primary

MeasureTime frameDescription
Walking speed3 monthsChange in walking speed at 3 month
Postural stability3 monthsChange in Fall Risk Test Score as measured by the BioDex Balance System.
Peak plantar pressure3 monthsChange in dynamic peak plantar pressure during barefoot walking.
Instruments of pain and disability3 monthsChange in answers on the following questionnaires: Revised Foot Function Index, the Medical Outcomes Study Short Form 36 (SF-36), Western Ontario and McMaster Universities Osteoarthritis Index.

Secondary

MeasureTime frameDescription
Arch Height Drop3 monthsChange in arch height in standing compared to sitting
Activities of Daily Living3 monthsChange in 50' walk time and pain, stair ascend/descend time and pain, and sit-to-stand.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026